Announced Wed, 22 Apr · 17:59 IST

<b>Format of Initial Disclosure to be made by an entity identified as a Large Corporate.</b><br/><br/> <table border=''1px''><tr> <td><b>Sr. No.</b></td> <td><b>Particulars</b></td> <td><b>Details</b></td> ....

Price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reaction · full curve 14 horizons · vs prior close
+2.4%1-day move
₹0.41
prior close
₹0.41
base price
After-mkt
timing
5m10m15m30m1D2D3D4D5D7D15D1M2M3M
+2.4+0.0+2.4+2.4+2.4+4.9-2.4+2.4-2.4-4.9+0.0-12.2-17.1-22.0
Up moveDown movePending
AI summary

Biogen Pharmachem Industries Ltd has informed BSE that it does not fall under the 'Large Corporate' category as defined by SEBI Circular SEBI/HO/DDHS/CIR/P/2018/144 dated November 26, 2018. This circular pertains to fund-raising by issuance of debt securities and related disclosure requirements for large entities. As the company does not qualify as a Large Corporate, it is not required to furnish Initial and Annual Disclosure for the financial year ended March 31, 2026. The company was formerly known as Sun Techno Overseas Limited. The filing is signed by Kelash Bunkar, Whole-time Director.

Likely market impact

This filing is neutral for shareholders. By confirming it is not a Large Corporate, the company avoids additional disclosure obligations related to debt issuance plans, which is typical for smaller or mid-sized companies with limited debt capital market activity.